William Tanner

Stock Analyst at Cantor Fitzgerald

(1.09)
# 2,778
Out of 4,667 analysts
5
Total ratings
25%
Success rate
8.75%
Average return

Stocks Rated by William Tanner

Prothena Corporation
Mar 4, 2019
Assumes: Overweight
Price Target: n/a
Current: $14.40
Upside: -
TherapeuticsMD
Aug 14, 2018
Maintains: Overweight
Price Target: $1,300$1,350
Current: $1.34
Upside: +100,646.27%
Xencor
Nov 29, 2017
Initiates: Overweight
Price Target: $33
Current: $23.72
Upside: +39.12%